Immunic (IMUX) Common Equity (2013 - 2026)
Immunic (IMUX) reported Common Equity of $127.58 million for Q2 2026, up 276.2% from $33.91 million a year earlier but down 15.6% from the prior quarter.
Powered by 
Analysis
Immunic (IMUX) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Immunic posted Common Equity of -$6.67 million.
- By year, Common Equity came in at $18.43 million in FY2024 (-36.3%), $28.93 million in FY2023 (-74.6%), $113.68 million in FY2022 (-10.6%) and $127.12 million in FY2021 (-19.9%).
- Five-year quarterly Common Equity spans a low of -$6.67 million in Q4 2025 and a high of $151.23 million in Q1 2026.
- Year over year, Common Equity gained in 1 of the last five quarters, with growth averaging 20.8%.
- The high point for year-over-year Common Equity in five years was Q2 2026 (growth of 276.2%); the low point was Q4 2023 (a decline of 74.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $151.23 million (Q1 2026), -$6.67 million (Q4 2025) and $10.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Immunic | 404.31 Mn | 404.31 Mn | - | 127.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127.58 Mn |
| Mar 31, 2026 | 151.23 Mn |
| Dec 31, 2025 | -6.67 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 33.91 Mn |
| Mar 31, 2025 | -5.29 Mn |
| Dec 31, 2024 | 18.43 Mn |
| Sep 30, 2024 | 41.22 Mn |
| Jun 30, 2024 | 63.57 Mn |
| Mar 31, 2024 | 83.58 Mn |
| Dec 31, 2023 | 28.93 Mn |
| Sep 30, 2023 | 48.41 Mn |
| Jun 30, 2023 | 69.28 Mn |
| Mar 31, 2023 | 91.22 Mn |
| Dec 31, 2022 | 113.68 Mn |
| Sep 30, 2022 | 108.81 Mn |
| Jun 30, 2022 | 127.85 Mn |
| Mar 31, 2022 | 137.96 Mn |
| Dec 31, 2021 | 127.12 Mn |
| Sep 30, 2021 | 145.47 Mn |
API Access
Immunic Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IMUX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IMUX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IMUX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();